Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dragos Inta

Showing results (41-50 of 68) with videos related to

Pageof 7
Sort By:
Frontiers in Behavioral Neuroscience|December 16, 2014
Inducible forebrain-specific ablation of the transcription factor Creb during adulthood induces anxiety but no spatial/contextual learning deficitsMiriam A Vogt, Dragos Inta, Alessia Luoni, et al.
Clinical Neuropharmacology|August 1, 2009
Clozapine-induced obsessive-compulsive syndromes improve in combination with aripiprazoleSusanne Englisch, Christine Esslinger, Dragos Inta, et al.
Neuropsychiatric Disease and Treatment|April 15, 2017
Modulation of the activity of <i>N</i>-methyl-d-aspartate receptors as a novel treatment option for depression: current clinical evidence and therapeutic potential of rapastinel (GLYX-13)Andrei-Nicolae Vasilescu, Nina Schweinfurth, Stefan Borgwardt, et al.
European Archives of Psychiatry and Clinical Neuroscience|February 18, 2018
Altered prepulse inhibition of the acoustic startle response in BDNF-deficient mice in a model of early postnatal hypoxia: implications for schizophreniaJuan M Lima-Ojeda, Anne S Mallien, Christiane Brandwein, et al.
Neuropharmacology|January 21, 2012
The mGlu5 receptor antagonist MPEP activates specific stress-related brain regions and lacks neurotoxic effects of the NMDA receptor antagonist MK-801: significance for the use as anxiolytic/antidepressant drugDragos Inta, Dragana Filipovic, Juan M Lima-Ojeda, et al.
Neuropharmacology|March 21, 2016
Puberty marks major changes in the hippocampal and cortical c-Fos activation pattern induced by NMDA receptor antagonistsIoana Inta, Emese Domonkos, Natascha Pfeiffer, et al.
European Archives of Psychiatry and Clinical Neuroscience|November 7, 2023
Psilocybin does not induce the vulnerability marker HSP70 in neurons susceptible to Olney's lesionsAna-Maria Iorgu, Andrei-Nicolae Vasilescu, Natascha Pfeiffer, et al.
The International Journal of Neuropsychopharmacology|August 16, 2022
Region-Specific Enhancement of c-fos Expression by Combined Treatment With NMDA Receptor Agonists and Antagonists With Antidepressant PotentialAndrei-Nicolae Vasilescu, Natascha Pfeiffer, Federica Terraneo, et al.
Frontiers in Behavioral Neuroscience|July 5, 2022
Comparative Severity Assessment of Genetic, Stress-Based, and Pharmacological Mouse Models of DepressionAnne Stephanie Mallien, Natascha Pfeiffer, Christiane Brandwein, et al.
Neuroscience Letters|June 18, 2014
Lack of protracted behavioral abnormalities following intermittent or continuous chronic mild hypoxia in perinatal C57BL/6 miceJuan M Lima-Ojeda, Miriam A Vogt, S Helene Richter, et al.
Pageof 7

Showing results (41-50 of 68) with videos related to

Sort By:
Pageof 7
Frontiers in Behavioral Neuroscience|December 16, 2014
Inducible forebrain-specific ablation of the transcription factor Creb during adulthood induces anxiety but no spatial/contextual learning deficitsMiriam A Vogt, Dragos Inta, Alessia Luoni, et al.
Clinical Neuropharmacology|August 1, 2009
Clozapine-induced obsessive-compulsive syndromes improve in combination with aripiprazoleSusanne Englisch, Christine Esslinger, Dragos Inta, et al.
Neuropsychiatric Disease and Treatment|April 15, 2017
Modulation of the activity of <i>N</i>-methyl-d-aspartate receptors as a novel treatment option for depression: current clinical evidence and therapeutic potential of rapastinel (GLYX-13)Andrei-Nicolae Vasilescu, Nina Schweinfurth, Stefan Borgwardt, et al.
European Archives of Psychiatry and Clinical Neuroscience|February 18, 2018
Altered prepulse inhibition of the acoustic startle response in BDNF-deficient mice in a model of early postnatal hypoxia: implications for schizophreniaJuan M Lima-Ojeda, Anne S Mallien, Christiane Brandwein, et al.
Neuropharmacology|January 21, 2012
The mGlu5 receptor antagonist MPEP activates specific stress-related brain regions and lacks neurotoxic effects of the NMDA receptor antagonist MK-801: significance for the use as anxiolytic/antidepressant drugDragos Inta, Dragana Filipovic, Juan M Lima-Ojeda, et al.
Neuropharmacology|March 21, 2016
Puberty marks major changes in the hippocampal and cortical c-Fos activation pattern induced by NMDA receptor antagonistsIoana Inta, Emese Domonkos, Natascha Pfeiffer, et al.
European Archives of Psychiatry and Clinical Neuroscience|November 7, 2023
Psilocybin does not induce the vulnerability marker HSP70 in neurons susceptible to Olney's lesionsAna-Maria Iorgu, Andrei-Nicolae Vasilescu, Natascha Pfeiffer, et al.
The International Journal of Neuropsychopharmacology|August 16, 2022
Region-Specific Enhancement of c-fos Expression by Combined Treatment With NMDA Receptor Agonists and Antagonists With Antidepressant PotentialAndrei-Nicolae Vasilescu, Natascha Pfeiffer, Federica Terraneo, et al.
Frontiers in Behavioral Neuroscience|July 5, 2022
Comparative Severity Assessment of Genetic, Stress-Based, and Pharmacological Mouse Models of DepressionAnne Stephanie Mallien, Natascha Pfeiffer, Christiane Brandwein, et al.
Neuroscience Letters|June 18, 2014
Lack of protracted behavioral abnormalities following intermittent or continuous chronic mild hypoxia in perinatal C57BL/6 miceJuan M Lima-Ojeda, Miriam A Vogt, S Helene Richter, et al.
Pageof 7